[VRTX] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 81.44%
YoY- 11.96%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 431,608 166,076 138,421 310,750 418,305 114,424 31,622 54.52%
PBT -18,021 -190,861 -158,689 -63,511 -14,405 -174,870 -200,006 -33.01%
Tax 18,130 30,131 693 -1,799 20,063 24,448 24,633 -4.97%
NP -64,525 -188,848 -159,382 -57,165 -64,931 -174,069 -200,006 -17.16%
Tax Rate - - - - - - - -
Total Cost 496,133 354,924 297,803 367,915 483,236 288,493 231,628 13.52%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -14.95 -113.71 -115.14 -18.40 -15.52 -152.13 -632.49 -46.39%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -0.26 -0.78 -0.68 -0.26 -0.31 -0.85 -1.00 -20.09%
EPS Diluted -0.26 -0.78 -0.68 -0.26 -0.31 -0.85 -1.00 -20.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.